相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients
Kazutaka Otsuji et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Impact of an Alternative Chromosome 17 Probe and the 2013 American Society of Clinical Oncology and College of American Pathologists Guidelines on Fluorescence in Situ Hybridization for the Determination of HER2 Gene Amplification in Breast Cancer
Alana R. Donaldson et al.
CANCER (2017)
Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR
Miguel Waterhouse et al.
ANNALS OF HEMATOLOGY (2016)
Mutant DNA quantification by digital PCR can be confounded by heating during DNA fragmentation
Qing Kang et al.
BIOTECHNIQUES (2016)
Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples
Yazhen Zhu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
Michael F. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods
Chih-Jian Lih et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method
Yanni Zhang et al.
PLOS ONE (2016)
Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations
Eleonora Zonta et al.
PLOS ONE (2016)
Multiplex quantification of four DNA targets in one reaction with Bio-Rad droplet digital PCR system for GMO detection
David Dobnik et al.
SCIENTIFIC REPORTS (2016)
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
Stephen Q. Wong et al.
BMC MEDICAL GENOMICS (2014)
HER2 testing: Current status and future directions
Edith A. Perez et al.
CANCER TREATMENT REVIEWS (2014)
HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice
A. M. Shaaban et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
Wedad M. Hanna et al.
MODERN PATHOLOGY (2014)
Multiplexed Target Detection Using DNA-Binding Dye Chemistry in Droplet Digital PCR
Geoffrey P. McDermott et al.
ANALYTICAL CHEMISTRY (2013)
Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
Heidrun Gevensleben et al.
CLINICAL CANCER RESEARCH (2013)
Droplet Digital PCR Measurement of HER2 Copy Number Alteration in Formalin-Fixed Paraffin-Embedded Breast Carcinoma Tissue
Phillip Belgrader et al.
CLINICAL CHEMISTRY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine
Elizabeth Day et al.
METHODS (2013)
Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples
Nicholas J. Heredia et al.
METHODS (2013)
Determination of HER2 Amplification Status on Tumour DNA by Digital PCR
Isaac Garcia-Murillas et al.
PLOS ONE (2013)
Heterogeneous HER2 Gene Amplification Impact on Patient Outcome and a Clinically Relevant Definition
Alastair I. Bartlett et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy
Chun Hing Tse et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
Andrew H. S. Lee et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Quantitative and sensitive detection of rare mutations using droplet-based microfluidics
Deniz Pekin et al.
LAB ON A CHIP (2011)
The gene-reduction effect of chromosomal losses detected in gastric cancers
Seung-Jin Hong et al.
BMC GASTROENTEROLOGY (2010)
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis
Caterina Marchio et al.
JOURNAL OF PATHOLOGY (2009)
Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma
AD Watters et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH) -: A fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression
RR Tubbs et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2000)
分享论文
